Mixed trend on the daily chart: above its 200-day average, below its 50-day · 50-day above the 200-day · SuperTrend down since Oct 2 · below the Ichimoku cloud · RSI 34 · MACD below its signal
None of the 29 investors followed here reported a position in CURA.TO in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a CURA.TO trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Sciarrone (Robert)Senior Officer of Issuer | — | 4.7K | — |
| Oct 5, 2026 | Sciarrone (Robert)Senior Officer of Issuer | Disposition in the public market at price 9.98 per share. | 1.4K | $14.29K |
| Sep 30, 2026 | Lyon (Camilo)Senior Officer of Issuer | — | 0 | — |
| Sep 30, 2026 | Mickelson (Daniel)Senior Officer of Issuer | — | 0 | — |
| Sep 8, 2026 | Clateman (Peter Laurence)Senior Officer of Issuer | Acquisition under a purchase/ownership plan at price 1.48 per share. | 22.2K | $32.87K |
| Sep 8, 2026 | Clateman (Peter Laurence)Senior Officer of Issuer | Disposition under a purchase/ownership plan at price 10.20 per share. | 10K | $102.00K |
| Sep 8, 2026 | Clateman (Peter Laurence)Senior Officer of Issuer | Disposition under a purchase/ownership plan at price 10.10 per share. | 3.3K | $33.68K |
| Sep 2, 2026 | Johansson (Karl)Director of Issuer | Disposition in the public market at price 9.59 per share. | 39K | $373.93K |
| Aug 30, 2026 | Curaleaf Holdings, Inc.Issuer | — | 105.4K | — |
| Aug 27, 2026 | Curaleaf Holdings, Inc.Issuer | Redemption, retraction, cancelation, repurchase at price 9.60 per share. | 40 | $384 |
| Aug 27, 2026 | Curaleaf Holdings, Inc.Issuer | Redemption, retraction, cancelation, repurchase at price 9.59 per share. | 100 | $958 |
| Aug 26, 2026 | Curaleaf Holdings, Inc.Issuer | Redemption, retraction, cancelation, repurchase at price 9.26 per share. | 100 | $926 |
| Aug 26, 2026 | Curaleaf Holdings, Inc.Issuer | Redemption, retraction, cancelation, repurchase at price 9.28 per share. | 500 | $4.64K |
| Aug 25, 2026 | Clateman (Peter Laurence)Senior Officer of Issuer | Acquisition under a purchase/ownership plan at price 1.48 per share. | 22.2K | $32.87K |
| Aug 25, 2026 | Clateman (Peter Laurence)Senior Officer of Issuer | Disposition under a purchase/ownership plan at price 9.43 per share. | 10K | $94.34K |
| Aug 25, 2026 | Clateman (Peter Laurence)Senior Officer of Issuer | Disposition under a purchase/ownership plan at price 9.43 per share. | 3.3K | $31.44K |
| Aug 24, 2026 | Curaleaf Holdings, Inc.Issuer | Redemption, retraction, cancelation, repurchase at price 9.85 per share. | 100 | $985 |
| Aug 24, 2026 | Curaleaf Holdings, Inc.Issuer | Redemption, retraction, cancelation, repurchase at price 9.82 per share. | 1K | $9.82K |
| Aug 24, 2026 | Jordan (Boris)10% Security Holder of Issuer | — | 24.8K | — |
| Aug 24, 2026 | Jordan (Boris)10% Security Holder of Issuer | — | 24.8K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -11.7 | 6.0 | -6.0 | 59.0 | 1.7 | 5.2 | -18.9 | 8.0 | 9.1 | -14.2 | +22.6% | ||
| 2025 | -15.6 | 2.1 | -31.1 | 12.8 | -24.0 | 0.9 | 64.3 | 138.6 | -15.1 | 3.1 | -18.0 | 5.2 | +52.2% |
| 2024 | 27.6 | -7.8 | 11.7 | 18.8 | -26.7 | -16.7 | 4.4 | -28.6 | 5.4 | -2.2 | -33.3 | -16.7 | −59.3% |
| 2023 | -11.1 | -5.0 | -23.0 | -9.5 | 12.8 | 5.7 | 19.6 | 2.2 | 22.0 | -34.4 | 17.5 | 17.2 | −5.5% |
| 2022 | -18.5 | -3.6 | 2.8 | -16.8 | 3.0 | -16.9 | 9.2 | 16.7 | -17.5 | 7.3 | 22.2 | -35.1 | −48.4% |
| 2021 | 1.0 | -0.3 | -14.3 | 0.9 | 2.1 | -21.6 | 1.0 | -7.4 | −34.9% |
Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway. In addition, the company operates a medical cannabis clinic and holds a pharmacy license. It serves the medical and adult-use cannabis markets through retail and wholesale channels. The company is based in Stamford, Connecticut.
Buy / hold / sell counts
No recent headlines.